Caroline Joy Springer

This inventor holds 41 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Cancer Therapeutics. Top assignees: Cancer Research Technology Limited, Cancer Research Campaign Technology Limited, The Institute of Cancer Research: Royal Cancer Hospital. Active years: 1994-2024.

USPTO Granted Patents = 41 (Patent Applications = 2)

% Patents Active = 61.0

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 3.7

ph-index = 12

Forward Citations = 447(Granted Patents)

Location History:

London, GB (1994 - 2001)
Surrey, GB (2005 - 2014)
Sutton, GB (1998 - 2023)
Manchester, GB (2022 - 2024)
Macclesfield, GB (2024)

Company Filing History:

18 out of 268

Cancer Research Technology Limited

patents

15 out of 62

Cancer Research Campaign Technology Limited

patents

11 out of 54

The Institute of Cancer Research: Royal Cancer Hospital

patents

4. 10 out of 13

Institute of Cancer Research: Royal Cancer Hospital (the)

Astex Therapeutics Limited

patents

7. 1 out of 1

Institute of Cancer Research: Royal Cancer Hosp. (the)

patent

8. 1 out of 1

Oxy Scientific Limited

patent

9. 1 out of 3

The Wellcome Trust Limited

patents

10. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2024

Loading Chart...

Areas of Expertise:

Lysyl Oxidase Inhibitors

Methylamine Derivatives

RAF Inhibitors

Pyrido Compounds

Nitrogen Mustard Prodrugs

Chemical Synthesis

Enzyme Prodrug Therapy

Drug Delivery Systems

Cytotoxic Prodrugs

Bacterial Nitroreductase

Therapeutic Compounds

Aryl-Quinoly Compounds

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12060360 - Lysyl oxidase inhibitors (2024-08-13),

2. 12018029 - Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors (2024-06-25),

3. 11608330 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer (2023-03-21),

4. 11325915 - Lysyl oxidase inhibitors (2022-05-10),

5. 10995088 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer (2021-05-04),

6. 10807974 - Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer (2020-10-20),

7. 10167282 - 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer (2019-01-01),

8. 10100053 - Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-b]pyrazin-3-one derivatives (2018-10-16),

9. 9820976 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2017-11-21),

10. 9725447 - 1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer (2017-08-08),

11. 9708317 - Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivatives (2017-07-18),

12. 9540372 - Pyrido[2,3-b]pyrazin-8-substituted compounds and their use (2017-01-10),

13. 9439893 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2016-09-13),

14. 9155737 - Pyrido[2,3-B]pyrazin-8-substituted compounds and their use (2015-10-13),

15. 9120789 - 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy (2015-09-01),

Title: The Innovative Journey of Caroline Joy Springer

Introduction: Caroline Joy Springer, a pioneering inventor hailing from Sutton, GB, has made significant contributions to the field of technology with her creative and forward-thinking approach.

Latest Patents: Caroline Joy Springer's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar-powered devices for sustainable living.

Career Highlights: Throughout her illustrious career, Caroline Joy Springer has been recognized for her groundbreaking work in the areas of clean energy, environmental sustainability, and smart home solutions. Her inventions have not only revolutionized the way we harness energy but have also paved the way for a greener future.

Collaborations: Caroline Joy Springer has collaborated with leading research institutions and universities to further her research and bring her innovative ideas to life. Her partnerships with like-minded individuals and organizations have been instrumental in driving progress in the field of renewable energy.

Conclusion: Caroline Joy Springer's passion for innovation and commitment to creating a more sustainable world have established her as a trailblazer in the realm of technology. Her dedication to pushing the boundaries of what is possible continues to inspire future generations of inventors and innovators.